Expression and clinical significance of lung-specific X protein mRNA in bronchial brushing specimens from patients with or without lung cancer

Respirology

Volumn 16, Issue 7, 2011, Pages 1076-1080

  Lv, Ming ^a   Wu, Ming Zhe ^a   Zhao, Yu Jie ^a   Yang, Di ^a   Wang, En Hua ^a   Wu, Guang Ping ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

bronchial brushing; liquid based cytology; lung cancer; lung specific X protein; reverse transcription polymerase chain reaction

Indexed keywords

LUNG SPECIFIC X PROTEIN; MESSENGER RNA; PROTEIN X; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BRONCHUS BIOPSY; CANCER DIAGNOSIS; CONTROLLED STUDY; CYTODIAGNOSIS; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TUBERCULOSIS;

ADULT; AGED; AGED, 80 AND OVER; BRONCHOSCOPY; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PHOSPHOPROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 80053335995     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2011.02008.x     Document Type: Article

References (17)

1. van der Drift MA, van der Wilt GJ, Thunnissen FB, et al,. A prospective study of the timing and cost-effectiveness of bronchial washing during bronchoscopy for pulmonary malignant tumors. Chest 2005; 128: 394-400. (Pubitemid 40994500)
2. Saltzstein SL, Harrell JH, Cameron T,. Brushings, washings, or biopsy? Obtaining maximum value from flexible fiberoptic bronchoscopy in the diagnosis of cancer. Chest 1977; 71: 630-2. (Pubitemid 8111566)
3. Mak VH, Johnston ID, Hetzel MR, et al,. Value of washings and brushings at fibreoptic bronchoscopy in the diagnosis of lung cancer. Thorax 1990; 45: 373-6. (Pubitemid 20184895)
4. Matsuda M, Horai T, Nakamura S, et al,. Bronchial brushing and bronchial biopsy: comparison of diagnostic accuracy and cell typing reliability in lung cancer. Thorax 1986; 41: 475-8. (Pubitemid 16089183)
5. Karahalli E, Yilmaz A, Türker H, et al,. Usefulness of various diagnostic techniques during fiberoptic bronchoscopy for endoscopically visible lung cancer: should cytologic examinations be performed routinely? Respiration 2001; 68: 611-14. (Pubitemid 34062935)
6. Iwao K, Watanabe T, Fujiwara Y, et al,. Isolation of a novel human lung-specific gene, LUNX, a potential molecular marker for detection of micrometastasis in non-smallcell lung cancer. Int. J. Cancer 2001; 91: 433-7. (Pubitemid 32115095)
7. Cheng M, Chen YY, Yu XQ, et al,. Diagnostic utility of LunX mRNA in peripheral blood and pleural fluid in patients with primary non-small cell lung cancer. BMC Cancer 2008; 31: 156-68.
8. Fan YB, Wang QS, Ye L, et al,. Clinical application of the SurePath liquid-based Pap test in cytological screening of bronchial brushing for the diagnosis of lung cancer. Cytotechnology 2010; 62: 53-9.
9. Jiang B, Wu GP, Zhao YJ, et al,. Transcription expression and clinical significance of TTF-1 mRNA in pleural effusion of patients with lung cancer. Diagn. Cytopathol. 2008; 36: 849-54.
10. Sun Y, Wu GP, Fang CQ, et al,. Diagnostic utility of MOC-31, HBME-1 and MOC-31 mRNA in distinguishing between carcinoma cells and reactive mesothelial cells in pleural effusions. Acta. Cytol. 2009; 53: 619-24.
11. Kurusu Y, Yamashita J, Ogawa M,. Detection of circulating tumor cells by reverse transcriptase-polymerase chain reaction in patients with resectable non-small-cell lung cancer. Surgery 1999; 126: 820-6. (Pubitemid 29523318)
12. Doeberitz MK, Lacroix J,. Nucleic acid based techniques for the detection of rare cancer cells in clinical samp les. Cancer Metastasis Rev. 1999; 18: 43-64. (Pubitemid 29411091)
13. Bingle CD, Bingle L,. Characterisation of the human plunc gene, a gene product with an upper airways and nasopharyngeal restricted expression pattern. Biochim. Biophys. Acta 2000; 1493: 363-7.
14. Sung YK, Moon C, Yoo JY, et al,. Plunc, a member of the secretory gland protein family, is up-regulated in nasal respiratory epithelium after olfactory bulbectomy. J. Biol. Chem. 2002; 277: 12762-9. (Pubitemid 34952638)
15. Weston W, LeClair E, Trzyna W, et al,. Differential display identification of plunc, a novel gene expressed in embryonic palate, nasal epithelium, and adult lung. J. Biol. Chem. 1999; 274: 13698-703.
16. Wallace MB, Block MI, Gillanders W, et al,. Accurate molecular detection of nonsmall cell lung cancer metastases in mediastinal lymph nodes sampled by endoscopic ultrasound-guided needle aspiration. Chest 2005; 127: 430-7. (Pubitemid 40229299)
17. Mitas M, Hoover L, Silvestri G, et al,. Lunx Is a Superior Molecular Marker for Detection of Non-Small Lung Cell Cancer in Peripheral Blood. J. Mol. Diagn. 2003; 5: 237-42. (Pubitemid 37407448)